Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Taken together, our data suggested that EGCG inhibits GC growth and reverses 5-FU resistance of GC through inactivation of TFAP2A/VEGF pathway and down-regulation of MDR-1 and P-gp expression.
|
29137307 |
2017 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
More significantly, the strong correlation of DCTPP1 and MDR1 expression was detectable in clinical GC samples.
|
27612427 |
2016 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Thus, we found that HIF-1α is closely associated with MDR in GC and that HIF-1α may suppress MDR1/P-gp, LRP and Bcl-2 expression by inhibiting miR-27a expression.
|
26292288 |
2015 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MTT assay, RT-PCR, Western blotting were employed to detect susceptibility of GC cells to chemotherapeutic agents (5-FU, L-OHP) in vitro, and expressions of ZNF139 and MDR associated genes MDR1/P-gp, MRP1, Bcl-2, Bax were also detected. siRNA specific to ZNF139 was transfected into MKN28 cells, then chemosensitivity of GC cells as well as changes of ZNF139 and MDR associated genes were detected.
|
24515389 |
2014 |
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This meta-analysis suggested that the MDR1 C3435T polymorphism is not associated with susceptibility to GC and PU.
|
24815441 |
2014 |
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
These preliminary results indicate that the c.3073A>C genetic polymorphism of the MDR1 gene is potentially related to the susceptibility to gastric cancer in the Chinese Han population.
|
24116826 |
2014 |
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study aimed to analyze the association between genetic variants of MDR1 gene and the susceptibility to gastric cancer in Chinese Han population.
|
23801278 |
2013 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Multiple drug resistance 1/P-glycoprotein (MDR1/p-gp) contributes to drug resistance via ATP-dependent drug efflux pumps and is overexpressed in many solid tumors including gastric cancer.
|
24377601 |
2013 |
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
No correlation was observed between the C3435T polymorphism of the MDR1 gene and GC risk or prognosis in the population studied.
|
22641402 |
2012 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Methylation status of MDR1 gene in noncancerous gastric mucosa would be useful for predicting GC occurrence.
|
20636108 |
2010 |
Stomach Carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
The methylation of the MDR1 promoter was estimated in both antral non-neoplastic mucosa and cancer lesions in 83 patients with gastric cancer using a methylation-specific PCR method.
|
19331170 |
2009 |
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In this preliminary data, the association with MDR1 C3435T polymorphism and risk for developing H. pylori-related gastric cancer and peptic ulcer in Japanese was low.
|
18644389 |
2008 |
Stomach Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We investigated the influences of MDR1 gene polymorphism on the risk of gastric cancer.
|
17608636 |
2007 |
Stomach Carcinoma
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
Luciferase reporter assay suggested that Runx3 inhibited the promoter activity of the MDR-1 and MRP-1 promoter in SGC7901 cells.
|
15756676 |
2005 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, ZNRD1 might influence transcription of the MDR1 gene and thus play an important role in multidrug resistance in gastric carcinoma.
|
15649014 |
2004 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
By introduction of anti-MDR1/P-gp shRNA expression vectors into the extremely high drug-resistant human gastric carcinoma cell line EPG85-257RDB, the MDR phenotype was completely reversed.
|
15375376 |
2004 |
Stomach Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
To detect the expression of glutathione S-transferase Pi(GST-pi), multidrug resistance-associated protein (MRP), lung-resistance protein(LRP), multidrug resistance gene1 (MDR1) and MGr1 antigen(MGr1-Ag) in the patients with primary gastric cancer and without any prior chemotherapy and to evaluate the correlations between them.
|
11205224 |
2001 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We conclude that the expression of MDR-1 in gastric cancer is high in Turkey, and this may be related to poor prognosis.
|
10446694 |
1999 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We specifically examine the magnitude and the biologic significance of multidrug resistance-1 (MDR-1) expression in human gastric cancer.
|
9649010 |
1998 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MDR1 RNA levels of gastric carcinoma specimens (n = 22) were determined by slot blot analysis.
|
8431845 |
1993 |
Stomach Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Northern blot analysis by pmdr1 probe showed that stomach cancer cell lines had no detectable level of MDR1 mRNA expression.
|
1735085 |
1992 |